TNF-α blockade with etanercept for successful therapy of refractory acute and chronic graft-versus-host disease.

被引：0
|
作者：
Oyama, Y [1 ]
Ali, Y [1 ]
Tallman, M [1 ]
Winter, J [1 ]
Falco, A [1 ]
O'Connor, N [1 ]
Fishman, MA [1 ]
Welles, C [1 ]
Williams, S [1 ]
Singhal, S [1 ]
Gordon, L [1 ]
Mehta, J [1 ]
机构：
[1] Northwestern Univ, Sch Med, Chicago, IL USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5214
引用
收藏
页码：360B / 360B
页数：1
相关论文
共 50 条
  • [31] Therapy of chronic graft-versus-host disease
    Arora, Mukta
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (02) : 271 - 279
  • [32] Infliximab for treatment of steroid refractory acute and chronic graft-versus-host disease
    Trenschel, R
    Trampenau, C
    Ditschkowski, M
    Elmaagacli, A
    Ottinger, H
    Steckel, N
    Biersack, H
    Peceny, R
    Beelen, D
    BONE MARROW TRANSPLANTATION, 2003, 31 : S128 - S129
  • [33] Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab
    Willenbacher, W
    Basara, N
    Blau, IW
    Fauser, AA
    Kiehl, MG
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 820 - 823
  • [34] Genetic factors influencing the development of acute and chronic graft-versus-host disease.
    Harper, JM
    Slayback, DL
    Allen, RD
    FASEB JOURNAL, 1998, 12 (05): : A1094 - A1094
  • [35] Infliximab for the treatment of severe steroid-refractory acute graft-versus-host disease.
    Patriarca, F
    Sperotto, A
    Prosdocimo, S
    Skert, C
    Morreale, G
    Dini, G
    Bandini, G
    Milone, G
    Corradini, P
    Peccatori, J
    Fanin, R
    Bosi, A
    Bacigalupo, A
    BLOOD, 2003, 102 (11) : 451B - 451B
  • [36] Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease
    Jurado, Manuel
    Vallejo, Carlos
    Perez-Simon, Jose A.
    Brunet, Salut
    Ferra, Christelle
    Balsalobre, Pascual
    Perez-Oteyza, Jaime
    Espigado, Ildefonso
    Romero, Antonio
    Caballero, Dolores
    Sierra, Jorge
    Ribera, Jose M.
    Diez, Jose L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (06) : 701 - 706
  • [37] Response to mycophenolate mofetil therapy for refractory chronic graft-versus-host disease
    Busca, A
    Locatelli, F
    Marmont, F
    Audisio, E
    Falda, M
    HAEMATOLOGICA, 2003, 88 (07) : 837 - 838
  • [38] Rituximab as salvage therapy for refractory sclerodermatous chronic graft-versus-host disease
    Namdaroglu, S.
    Iskender, D.
    Dal, M. S.
    Cakar, M. K.
    Tekgunduz, E.
    Altuntas, F.
    HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2019, 27 (01): : 12 - 18
  • [39] Therapy of acute and chronic graft-versus-host disease with monoclonal antibodies
    Gramatzki, M.
    ONKOLOGIE, 2010, 33 : 109 - 109
  • [40] Steroid-Refractory Acute Graft-versus-Host Disease: Is There an Effective Therapy?
    Antin, Joseph H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : 146 - 148
12345